Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | RHOC | P08134 | 1/20 | 0.44 |
| ▸ | RHOA | P61586 | 1/20 | 0.44 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | EP300 | Q09472 | 1/20 | 0.43 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL845008 | 0.88 | ALDH1A1 (0.54) | CYP2C9CYP2C19ALDH1A1MAPK1HTT | |
| SCHEMBL844996 | 0.87 | CYP2C9 (0.50) | CYP2C9CYP2C19ALDH1A1MAPK1HTT | |
| SCHEMBL845257 | 0.87 | TRPV1 (0.48) | CYP2C9CYP2C19ALDH1A1MAPK1HTT | |
| SCHEMBL845349 | 0.85 | HCRTR1 (0.53) | CYP2C9CYP2C19ALDH1A1MAPK1HTT | |
| SCHEMBL845046 | 0.85 | CYP2C9 (0.46) | CYP2C9CYP2C19ALDH1A1MAPK1HTT | |
| SCHEMBL845350 | 0.85 | MAPK1 (0.49) | CYP2C9CYP2C19ALDH1A1MAPK1HTT | |
| SCHEMBL845007 | 0.85 | PABPC1 (0.49) | CYP2C9CYP2C19ALDH1A1MAPK1HTT | |
| SCHEMBL845458 | 0.85 | CYP2C9 (0.46) | CYP2C9CYP2C19ALDH1A1MAPK1HTT | |
| SCHEMBL845013 | 0.85 | CYP2C9 (0.46) | CYP2C9CYP2C19ALDH1A1MAPK1HTT | |
| SCHEMBL845131 | 0.85 | PABPC1 (0.49) | CYP2C9CYP2C19ALDH1A1MAPK1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143288-B2 | Inhibitors of HCV replication | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| US-8143288-B2 | Inhibitors of HCV replication | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| EP-1893573-B1 | INHIBITORS OF HCV REPLICATION | BRISTOL MYERS SQUIBB CO (US) | 2010-07-21 | — | — | EP | disclosed |